698 related articles for article (PubMed ID: 19258511)
1. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
Avnet S; Sciacca L; Salerno M; Gancitano G; Cassarino MF; Longhi A; Zakikhani M; Carboni JM; Gottardis M; Giunti A; Pollak M; Vigneri R; Baldini N
Cancer Res; 2009 Mar; 69(6):2443-52. PubMed ID: 19258511
[TBL] [Abstract][Full Text] [Related]
2. Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58.
Viereck V; Siggelkow H; Pannem R; Braulke T; Scharf JG; Kübler B
J Cell Biochem; 2007 Sep; 102(1):28-40. PubMed ID: 17372931
[TBL] [Abstract][Full Text] [Related]
3. Effect of IGFBP-3 on IGF- and IGF-analogue-induced insulin-like growth factor-I receptor (IGFIR) signalling.
Devi GR; Graham DL; Oh Y; Rosenfeld RG
Growth Horm IGF Res; 2001 Aug; 11(4):231-9. PubMed ID: 11735239
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor receptor I targeting in epithelial ovarian cancer.
Gotlieb WH; Bruchim I; Gu J; Shi Y; Camirand A; Blouin MJ; Zhao Y; Pollak MN
Gynecol Oncol; 2006 Feb; 100(2):389-96. PubMed ID: 16300820
[TBL] [Abstract][Full Text] [Related]
5. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
[TBL] [Abstract][Full Text] [Related]
6. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
Cunningham MP; Thomas H; Marks C; Green M; Fan Z; Modjtahedi H
Int J Oncol; 2008 Nov; 33(5):1107-13. PubMed ID: 18949375
[TBL] [Abstract][Full Text] [Related]
7. Insulin receptor activation by IGF-II in breast cancers: evidence for a new autocrine/paracrine mechanism.
Sciacca L; Costantino A; Pandini G; Mineo R; Frasca F; Scalia P; Sbraccia P; Goldfine ID; Vigneri R; Belfiore A
Oncogene; 1999 Apr; 18(15):2471-9. PubMed ID: 10229198
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
Zhang H; Pelzer AM; Kiang DT; Yee D
Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I inhibits the progression of human U-2 OS osteosarcoma cells towards programmed cell death through interaction with the IGF-I receptor.
Herzlieb N; Gallaher BW; Berthold A; Hille R; Kiess W
Cell Mol Biol (Noisy-le-grand); 2000 Feb; 46(1):71-7. PubMed ID: 10726973
[TBL] [Abstract][Full Text] [Related]
10. Circulating concentrations of IGF-I and IGFBP-3 are not predictive of incidence or clinical behavior of pediatric osteosarcoma.
Rodriguez-Galindo C; Poquette CA; Daw NC; Tan M; Meyer WH; Cleveland JL
Med Pediatr Oncol; 2001 Jun; 36(6):605-11. PubMed ID: 11344491
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of IGF-I and insulin receptor isoforms in HPV positive and negative human cervical cancer cell lines.
Serrano ML; Sánchez-Gómez M; Bravo MM; Yakar S; LeRoith D
Horm Metab Res; 2008 Oct; 40(10):661-7. PubMed ID: 18711691
[TBL] [Abstract][Full Text] [Related]
12. Levels of plasma insulin-like growth factor I (IGF I), IGF II, IGF binding proteins, type 1 IGF receptor and growth hormone binding protein in community-dwelling elderly subjects with no malnutrition and no inflammation.
Raynaud-Simon A
J Nutr Health Aging; 2003; 7(4):267-73. PubMed ID: 12917753
[TBL] [Abstract][Full Text] [Related]
13. Dibutyryl cyclic adenosine monophosphate differentially regulates cell proliferation in low and high alkaline phosphatase SaOS-2 human osteosarcoma cells: evidence for mediation by the insulin-like growth factor-II system.
Mohan S; Strong DD; Hilliker S; Malpe R; Lee K; Farley J; Baylink DJ
J Cell Physiol; 1993 Sep; 156(3):462-8. PubMed ID: 7689570
[TBL] [Abstract][Full Text] [Related]
14. In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.
Sciacca L; Mineo R; Pandini G; Murabito A; Vigneri R; Belfiore A
Oncogene; 2002 Nov; 21(54):8240-50. PubMed ID: 12447687
[TBL] [Abstract][Full Text] [Related]
15. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
Law JH; Habibi G; Hu K; Masoudi H; Wang MY; Stratford AL; Park E; Gee JM; Finlay P; Jones HE; Nicholson RI; Carboni J; Gottardis M; Pollak M; Dunn SE
Cancer Res; 2008 Dec; 68(24):10238-46. PubMed ID: 19074892
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor family in malignant haemangiopericytomas: the expression and role of insulin-like growth factor I receptor.
Pavelić K; Pavelić ZP; Cabrijan T; Karner I; Samarzija M; Stambrook PJ
J Pathol; 1999 May; 188(1):69-75. PubMed ID: 10398143
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of receptors for IGF-I and insulin; evidence for hybrid insulin/IGF-I receptor in human coronary artery endothelial cells.
Chisalita SI; Nitert MD; Arnqvist HJ
Growth Horm IGF Res; 2006 Aug; 16(4):258-66. PubMed ID: 16914341
[TBL] [Abstract][Full Text] [Related]
18. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W
J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767
[TBL] [Abstract][Full Text] [Related]
19. Urokinase type plasminogen activator receptor is involved in insulin-like growth factor-induced migration of rhabdomyosarcoma cells in vitro.
Gallicchio MA; Kaun C; Wojta J; Binder B; Bach LA
J Cell Physiol; 2003 Oct; 197(1):131-8. PubMed ID: 12942549
[TBL] [Abstract][Full Text] [Related]
20. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.
Schlenska-Lange A; Knüpfer H; Lange TJ; Kiess W; Knüpfer M
Anticancer Res; 2008; 28(2A):1055-60. PubMed ID: 18507054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]